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SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of Lactobacillus kefiri (DSM 
19455) as a silage additive for all animal species
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Lactobacillus kefiri is intended to improve the ensiling process at a dose of 5   10
7 CFU/kg fresh material. This 
species  is  considered  by  EFSA  to  be  suitable  for  the  qualified  presumption  of  safety  approach  to  safety 
assessment. As the identity of the strain has been established and no resistance to antibiotics of human and 
veterinary clinical significance was detected, the use of the strain in the production of silage is presumed safe for 
livestock species, consumers of products from animals fed the treated silage and for the environment. Given the 
proteinaceous nature of the active agent and the high dusting potential of the preparation tested, the FEEDAP 
Panel considers it prudent to treat this additive as a skin and respiratory sensitiser. It is also considered an 
irritant. The results of three efficacy studies indicated that L. kefiri has the potential to improve the aerobic 
stability of silage from forages with dry matter content above 40 % at the inclusion level of 5   10
7 CFU/kg 
forage. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety for 
the target animals, consumer, user and the environment and on the efficacy of a product based on a 
specific strain of Lactobacillus kefiri, when used individually as a technological additive intended to 
improve the ensiling process at a proposed dose of 5   10
7 CFU/kg fresh material. 
The species L. kefiri is considered by EFSA to be suitable for the qualified presumption of safety 
(QPS) approach to safety assessment. Therefore, it does not require any specific demonstration of 
safety  other  than  confirming  the  susceptibility  to  antibiotics  of  human  and  veterinary  clinical 
significance. As the identity of the strain has been clearly established and no antibiotic resistance of 
concern was detected, the use of the strain in the production of silage is presumed safe for livestock 
species, consumers of products from animals fed the treated silage and for the environment. 
Although users at the farm level are exposed to the additive for only a short period of time when 
preparing the aqueous suspension, in the absence of data, its potential to be irritant and/or to act as 
skin/respiratory  sensitiser cannot  be excluded. The dustiness  of  the  preparation  tested indicated  a 
potential for users to be exposed via inhalation. Given the proteinaceous nature of the active agent, the 
additive  should  be  considered  to  have the  potential  to  be a  skin/respiratory  sensitiser  and treated 
accordingly. 
Three studies carried out in laboratory-scale silos are described. Each lasted at least 90 days and used 
samples  of  grass  and  whole-crop  maize  of  differing  water-soluble  carbohydrate  content  and 
representing materials easy and moderately difficult to ensile. In each case, replicate silos containing 
treated forage at 5   10
7 CFU/kg of silage were compared with identical silos containing the same but 
untreated forage. L. kefiri showed the potential to improve the aerobic stability of silage from forages 
with dry matter content above 40 % at the inclusion level of 5   10
7 CFU/kg forage.. Lactobacillus kefiri for animal species 
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the  rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7.  
The European Commission received a request from  Biomin GmbH
5 for authorisation of the product 
Lactobacillus kefiri (DSM 19455), when used as a feed additive for all animal species (category: 
technological additive; functional group: silage additive) under the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the 
applicant  the  technical  dossier  in  support  of  this  application.
6  According  to  Article  8  of  that 
Regulation, EFSA, after verifying the particulars and doc uments submitted by the applicant, shall 
undertake an assessment in order to determine whether the feed additive complies with the conditions 
laid down in Article 5. The particulars and documents in support of the application were considered 
valid by EFSA as of 4 September 2012. 
The product Lactobacillus kefiri (DSM 19455) has not been previously authorised in the European 
Union (EU). 
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animal(s), consumer, user and the environment and the efficacy of the product 
Lactobacillus kefiri (DSM 19455), when used under the conditions described in Table 1. 
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5   Biomin Holding GmbH, Industriestraße 21, 3130 Herzogenburg, Austria. 
6   EFSA Dossier reference: FAD-2012-0018. Lactobacillus kefiri for animal species 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   Lactobacillus kefiri BIO 94 IFA 94, DSM 19455 
Registration number/EC 
No/No 
- 
Category(-ies) of additive  Technological Additives 
Functional group(s) of additive  1 k Silage additives 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
 
Method of analysis 
 
Preparation of Lactobacillus 
kefiri BIO 94 IFA 94, DSM 
19455 
Not applicable 
compliant with EU law 
on microbial quality, 
heavy metals, toxins 
and undesirable 
substances 
EN 15787:2009 
 
Trade name   - 
Name of the holder of 
authorisation  
- 
 
Conditions of use 
Species or 
category of animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
  CFU/kg of complete feedingstuffs 
All animal species 
and categories         
 
Other provisions and additional requirements for the labeling 
Specific conditions or restrictions for 
use   store in cool, dry place (room temperature or lower) 
Specific conditions or restrictions for 
handling 
Face  mask,  goggles  and  gloves  recommended.  Use  original 
container. When using do not eat, drink or smoke. After use wash 
hands and face. Avoid contac with eyes. Change and clean spoiled 
work clothing 
Post-market monitoring  
  not applicable 
Specific conditions for use in 
complementary feedingstuffs  
 
not applicable 
 
Maximum Residue Limit (MRL)  
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
       Lactobacillus kefiri for animal species 
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ASSESSMENT 
1.  Introduction 
Six genera of lactic acid-producing bacteria, including Lactobacillus, are commonly associated with 
forage  species  and  collectively  contribute  to  the  natural  ensiling  process.  The  present  application 
concerns  a  strain  of  Lactobacillus  kefiri  intended  to  be  added  to  forages  to  promote  ensiling 
(technological additive, functional group: silage additive) for eventual use in the silage for all animal 
species.  This  species  of  Lactobacillus  is  considered  by  EFSA  to  be  suitable  for  the  qualified 
presumption  of  safety  (QPS)  approach  to  safety  assessment (EFSA,  2007, 2012a). This  approach 
requires the identity of the strain to be conclusively established and evidence that that it does not show 
resistance to antibiotics of human and veterinary importance to be demonstrated. 
2.  Characterisation 
2.1.  Characterisation of the active substance 
The L. kefiri strain was isolated from sauerkraut and has been deposited in the Deutsche Sammlung 
von  Mikroorganismen  und  Zellkulturen  with the  accession  number  DSM  19455.
7  It  has not been 
genetically modified. Taxonomic identification of  the strain was  achieved by phenotypic tests and 
sequence analysis of the 16S rRNA gene.
8 Pulsed-field gel electrophoresis (PFGE) with AscI and SfiI 
is used as a strain-specific method of detection.
9 The same technique was used to  assess genetic 
stability after several generations and the  pattern has remained unchanged since  the DSM 19455 
deposition in 2007.
10  
The strain was tested for antibiotic susceptibility using the broth microdilution method. The battery of 
antibiotics tested included  those  recommended by EFSA (2012b).
11  In addition,  susceptibility  to 
neomycin,  ciprofloxacin,  linezolid  and  rifampicin  was  examined.  As  all   minimum  inhibitory 
concentration (MIC) values were equal to or below the cut-off values defined by the FEEDAP Panel, 
no further investigation is required. Only in the case of chloramphenicol  was  the cut-off value 
exceeded by a single dilution. This is within the normal variation around a mean and is not considered 
to be cause for concern by the FEEDAP Panel.  
2.2.  Production and characterisation of the product 
The manufacturing process has been detailed and material safety datasheets for cryoprotectants and 
carrier materials were provided in the dossier. All excipients are of food grade and do not introduce 
safety  concerns.  Data  on  five  production  batches  showed  that  the  minimum  specification  (1   
10
10 CFU/g additive)
 was exceeded in all cases (mean 1   10
11 CFU/g additive).
12 
The additive is routinely monitored for microbial contamination at various points in the manufacturing 
process and in the final product. Limits are set for  coliforms  (< 10 CFU/g additive),  yeasts  and 
filamentous  fungi  (<10 CFU/g  additive),  Escherichia  coli  (< 10 CFU/g  additive)  and  Salmonella 
(absence in 25 g additive). Data from five batches confirmed compliance with the set microbiological 
values.
13 
Given the nature of the fermentation medium and the food -grade excipients, the probability of 
contamination with heavy metals or mycotoxins is considered to be low and consequently not included 
in routine monitoring. Three batches of the additive were, however, sent for analysis to confirm  that 
                                                       
7  Technical dossier/Section II/Annex II-26. 
8  Technical dossier/Section II/Annexes II-27. 
9  Technical dossier/Section II/Annexes II-28. 
10 Technical dossier/Section II/Annex II-29. 
11  Technical dossier/Section II/Annexes II-30. 
12 Technical dossier/Section II/Annexes II-3 to 7. 
13 Technical dossier/Section II/Annexes II-9 to 13. Lactobacillus kefiri for animal species 
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this was indeed the case.
14 Aflatoxins B1, B2, G1 and G2, the metals lead, mercury and cadmium and 
arsenic could not be detected. 
Three batches of the additive (formulation declared to be as intended to be marketed) were examined 
for particle size distribution by sieving. The measurements showed that 9.8 %, by volume, of the 
additive  consisted of  particles  with  diameters  below  50 µm;  no  information  on  the  percentage  of 
particles with diameter < 10 µm was given.
15 The same batches were used to measure the dusting 
potential with a Heubach dustometer. The mean value was 5.6 g/m
3, which is considered high.
16 
2.3.  Stability and homogeneity 
The stability of three batches of the additive was studied in sealed aluminium foil bags or sealed 
plastic containers at 4 and 22 °C for up to 18 months.
17 Essentially no losses were observed under the 
conditions tested. 
Stability in water was tested using three batches of the additive diluted in water to an average level of 
7.8   10
5 CFU/mL and stored at 22 °C.
18 The average count after 48 hours was 3.2   10
5 CFU/mL, 
with a survival rate of 41 %. The applicant recommends the use of the solution within hours after 
dilution in water. 
2.4.  Conditions of use 
The additive is intended for use with forages for all animal species at a proposed minimum dose of 
5   10
7 CFU/kg fresh matter and to be applied to silage directly (granular application) or by spraying 
as an aqueous suspension (liquid application). 
2.5.  Evaluation  of  the  analytical  methods  by  the  European  Union  Reference 
Laboratory (EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of the active agent 
in animal feed. The Executive Summary of the EURL report can be found in the Appendix. 
3.  Safety 
In the view of the FEEDAP Panel, the antibiotic susceptibility qualification has been met and the 
identity  of  the  strain  established.  Consequently,  L.  kefiri  is  suitable  for  QPS  approach  to  safety 
assessment and no further assessment of safety for the target species, consumers of products from 
animals fed treated silage or the environment is required. 
No data were provided on skin/eye irritation caused by the additive. Although users at the farm level 
are exposed to the additive for only a short period of time when preparing the aqueous suspension, in 
the absence of data the potential of the additive to be irritant and/or to act as skin sensitiser cannot be 
excluded. The dustiness of the preparation tested indicated a potential for users to be exposed via 
inhalation. Given the proteinaceous nature of the active agent, the additive should be considered to 
have the potential to be a respiratory sensitiser and treated accordingly. 
Once an active agent has been authorised as a silage additive, different formulations can be placed on 
the  market  with  reference  to  that  authorisation.  The  applicant  listed  as  carrier  materials  and 
cryoprotectants inulin and soy peptone, which can be added in a concentration range that would allow 
multiple formulations of the additive to be produced and, consequently, not all forms can be directly 
tested for user safety. However, for assessing the safety for the user of the additive, the active agent is 
                                                       
14 Technical dossier/Section II/Annexes II-14 to 17. 
15 Technical dossier/Section II/Annexes II-18 to 20. 
16 Technical dossier/Section II/ Annexes II-21 to 23. 
17 Technical dossier/Section II/ Annex II-44. 
18 Technical dossier/Supplementary information November 2012. Lactobacillus kefiri for animal species 
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the  principal  focus  provided  that  other  components  do  not  introduce  concerns.  For  this  specific 
product, the excipients used would not introduce any additional risk as the active agent is already 
regarded as hazardous by any route of exposure.  
4.  Efficacy 
A total of three laboratory studies are described, each using different forage materials and lasting at 
least 90 days (91, 93 and 90 days for studies 1, 2 and 3, respectively). All of the studies used 5.8-L 
mini-silos. In each case, the contents of three replicate treated silos were sprayed with the additive at 
5   10
7 CFU/kg forage. Forage for the control silos was sprayed with an equal volume of water but 
without the additive. Forage was packed in the silos at 6 bars pressure. Ambient temperature was 
controlled at 22 (±2) °C. The forages used in the three studies are shown in Table 2, and represented 
easy (study 1) and moderately difficult to ensile materials (studies 2 and 3), as defined in Regulation 
(EC) No 429/2008.
19 
Table 2:   Forages used in the efficacy studies of Lactobacillus kefiri DSM 19455 as silage additive 
Study  Forage  Dry matter content 
(%) 
Water soluble 
carbohydrate content 
(% fresh matter) 
1
20  Grass (second cut of a permanent grassland)  65.0  4.3 
2
21  Whole crop maize (dough ripe stage)  43.5  2.9 
3
22  Whole crop maize (full ripe stage)  42.7  2.0 
 
Replicate silos were opened at the end of the experiments and the contents were analysed for dry 
matter  content,  pH,  lactic  acid  and  volatile  fatty  acids  concentration,  ethanol,  ammonia  (as  a 
percentage  of  total  nitrogen),  as  well  as  aerobic  stability  (using  a  rise  of  3 °C  as  indicative  of 
instability and spoilage)  (Table 2). Statistical analysis was carried out using  non-parametric tests 
(Kruskal–Wallis test) comparing differences between treated and untreated samples.
 23  
Table 3:   Summary of the analysis of ensiled material recovered at the end of the experiments with 
Lactobacillus kefiri DSM 19455 
Study  Treatment 
(CFU/kg) 
Dry 
matter 
loss  
(%) 
pH 
Lactic acid 
(% dry 
matter) 
Acetic acid 
(% dry 
matter) 
NH3-N 
(% total N) 
Aerobic 
stability 
(days) 
1
  0  7.4  5.5  0.0  0.6  3.3  4.3 
5   10
7  3.7  4.8*  2.5*  1.4*  3.5  13.0* 
2 
0  0.6  4.0  4.1  0.9  5.0  2.1 
5   10
7  2.2*  4.1*  3.2*  3.2*  7.4  7.7* 
3 
0  4.1  4.1  3.3  0.7  6.4  3.6 
5   10
7  2.7  4.4*  0.6*  3.6*  8.3  16.7* 
*Significantly different from control at P < 0.05. 
                                                       
19 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC) 
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of 
applications and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1–65.  
20 Technical dossier/Section IV/Annexes IV_01 and IV_04. 
21 Technical dossier/Section IV/Annexes IV_01 and IV_03. 
22 Technical dossier/Section IV/Annexes IV_01 and IV_05. 
23 Technical dossier/Supplementary information December 2012/SIn addendum 19455. Lactobacillus kefiri for animal species 
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L. kefiri DSM 19455 significantly improved aerobic stability 90 days after ensiling  by increasing 
acetic acid production during fermentation (Table 3). L. kefiri DSM 19455 also significantly reduced 
silage pH within the first seven days in all trials (data not shown), although, after 90 days of ensiling, 
this decrease in pH remained only in study 1. L. kefiri DSM 19455 improved aerobic stability of silage 
from easy and moderately difficult to ensile materials at the inclusion level of 5   10
7 CFU/kg forage. 
CONCLUSIONS 
As the identity of the strain of Lactobacillus kefiri has been established and no antibiotic resistance of 
concern  detected,  following  the  QPS  approach  to  safety  assessment,  the  use  of  the  strain  in  the 
production of silage is considered safe for target species, for consumers of products from animals fed 
treated silage and for the environment.  
Although users at the farm level are exposed to silage additive for only a short period of time when 
preparing the aqueous suspension, its potential to be  an irritant and/or to act as a skin sensitiser cannot 
be excluded. Given the proteinaceous nature of the active agent and the high dusting potential of the 
product tested, the FEEDAP Panel considers it prudent to treat this additive as a skin and respiratory 
sensitiser.  
L. kefiri has the potential to improve the aerobic stability of silage from forages with dry matter 
content above 40 % at the inclusion level of 5   10
7 CFU/kg forage. 
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APPENDIX 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for Lactobacillus kefiri
24 
In the current application authorisation is sought under Article 4(1) for Lactobacillus kefiri BIO 94 
IFA  94  –  DSM  19455,  under  the  category/functional  group  1(k),  ''technological  additives/silage 
additives'',  according  to  the  classification  system  of  Annex  I  of  Regulation  (EC)  No  1831/2003. 
Specifically,  authorisation  is  sought  for  the  use  of  the  feed  additive  for  all  animal  species  and 
categories.  The  feed  additive  is  to  be  placed  on  the  market  as  a  powder, containing  a  minimum 
concentration of 1 x 10
10 CFU/g of Lactobacillus kefiri BIO 94 IFA 94 – DSM 19455. It is intended to 
be  mixed  directly  into  silage  or  suspended  in  water  and  sprayed  on  silage  with  a  minimum 
concentration of 5 x 10
7 CFU/kg fresh forage.  
For enumeration of Lactobacillus kefiri BIO 94 IFA 94 – DSM 19455 in feed additive, the Applicant 
submitted  the  ring-trial  validated  spread  plate  CEN  method  (EN  15787),  using  MRS  agar.  The 
performance characteristics of the method reported after logarithmic transformation are: 
- a standard deviation for repeatability (Sr) of 0.24 log10 CFU/g; 
- a standard deviation for reproducibility (SR) ranging from 0.29 to 0.38 log10 CFU/g; 
and 
- a limit of detection (LOD) of 10
5 CFU/kg feedingstuffs. 
Based on the performances characteristics presented, the EURL recommends for official control, the 
CEN method (EN 15787) for the determination of Lactobacillus kefiri BIO 94 IFA 94 – DSM 19455 
in the feed additive per se. 
The Applicant did not provide any experimental method or data for the determination of Lactobacillus 
kefiri BIO 94 IFA 94 – DSM 19455 in silage. Furthermore, the unambiguous determination of the 
content of Lactobacillus kefiri BIO 94 IFA 94 – DSM 19455 added to silage is not achievable by 
analysis. Therefore the EURL cannot evaluate nor recommend any  method for official control to 
determine Lactobacillus kefiri BIO 94 IFA 94 – DSM 19455 in silage. 
Molecular methods were used by the Applicant to identify the active agent in the feed additive. The 
EURL  recommends  for  official  control  Pulsed  Field  Gel  Electrophoresis  (PFGE),  a  generally 
recognised  standard  methodology  for  microbial  identification.  Further  testing  or  validation  of  the 
methods to be performed through the consortium of National Reference Laboratories as specified by 
article 10 (Commission Regulation (EC) No 378/2005) is not considered necessary. 
                                                       
24 The  full  report is  available on  the  EURL  website:  http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
2012-0018.pdf 
 